Subscribe to RSS

DOI: 10.1055/s-0045-1812849
Oral Biopsy Score: A Quantitative Approach to Clinical Decision Making for Biopsies in Suspicious Oral Lesions
Authors
Funding None.
Abstract
Oral potentially malignant lesions are often underdiagnosed, leading to malignant transformation, progression, and spread of disease. It is also responsible for poor survival outcomes. To save these life years, early detection is a must. Unfortunately, it requires specialist access in many clinical settings. For faster, uniform screening, a quantitative approach, the oral biopsy score (OBS), has been formulated for risk stratification and sooner decision making. The OBS consists of risk factors such as tobacco/alcohol/areca nut use, size of the lesion, morphology, duration, location, and induration of the lesion. Each of these categories has an upper and lower score assigned. Depending on the added score, the inference will guide us in performing the biopsy or keeping it under surveillance. We advocate for validation of the OBS through multicentric prospective studies to assess its diagnostic performance. Incorporation into artificial intelligence-assisted image analysis will enhance the accuracy of the diagnosis. Ultimately, we believe the OBS can play a pivotal role in early detection of oral cancer, leading to reduction in morbidity and improvement in survival.
Keywords
biopsy - oral lesions - oral cancer - leukoplakia - erythroplakia - oral potentially malignant disorder - oral biopsy scorePatient Consent
Patient consent is not required.
Publication History
Article published online:
03 November 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Warnakulasuriya S, Kujan O, Aguirre-Urizar JM. et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis 2021; 27 (08) 1862-1880
- 2 Joshi P, Nair S, Chaturvedi P, Nair D, Agarwal JP, D'Cruz AK. Delay in seeking specialized care for oral cancers: experience from a tertiary cancer center. Indian J Cancer 2014; 51 (02) 95-97
- 3 van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010; 46 (06) 423-425
- 4 Home [Internet]. Accessed September 5, 2025 at: https://monographs.iarc.who.int
- 5 Asthana S, Labani S, Kailash U, Sinha DN, Mehrotra R. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine Tob Res 2019; 21 (09) 1162-1171
- 6 Gandini S, Botteri E, Iodice S. et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008; 122 (01) 155-164
- 7 Singhavi HR, Singh A, Bhattacharjee A, Talole S, Dikshit R, Chaturvedi P. Alcohol and cancer risk: a systematic review and meta-analysis of prospective Indian studies. Indian J Public Health 2020; 64 (02) 186-190
- 8 Warnakulasuriya S, Chen THH. Areca nut and oral cancer: evidence from studies conducted in humans. J Dent Res 2022; 101 (10) 1139-1146
- 9 Pimenta-Barros LA, Ramos-García P, González-Moles MÁ, Aguirre-Urizar JM, Warnakulasuriya S. Malignant transformation of oral leukoplakia: systematic review and comprehensive meta-analysis. Oral Dis 2025; 31 (01) 69-80
- 10 Barfi Qasrdashti A, Habashi MS, Arasteh P, Torabi Ardakani M, Abdoli Z, Eghbali SS. Malignant transformation in leukoplakia and its associated factors in Southern Iran: a hospital based experience. Iran J Public Health 2017; 46 (08) 1110-1117
- 11 Wadde KR, Gajare PP, Sachdev SS, Singhavi HR. Prevalence and malignant transformation rate of oral erythroplakia worldwide - a systematic review. Ann Maxillofac Surg 2024; 14 (01) 76-80
